Fig. 5From: C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysisCCR5 expression in synovial biopsies of RA and control and CCR5 expression at baseline and after six months of tDMARDs treatment. The expression of the chemokine receptor was searched in a microarray dataset (GSE77298) of synovial biopsies of RA and healthy controls. A paired T-test was used for comparisonBack to article page